First proof of concept for a therapy to treat patients with NMNAT1-associated disease
September 16, 2020Molecular Therapy: Methods & Clinical Development Vol. 18 September 2020 ยช 2020 Authors from the Ocular Genomics Institute and Grousebeck Gene therapy Center have published the first proof of concept for a therapy to treat patients with NMNAT1-associated disease. No treatment is available for nicotinamide mononucleotide... Read More
Janey Wiggs Selected to Receive 2022 Weisenfeld Award
September 16, 2020Janey L. Wiggs (Mass Eye and Ear) has been selected by the Association for Research in Vision and Ophthalmology (ARVO) to receive the 2022 Mildred Weisenfeld Award for Excellence in Ophthalmology in recognition of her distinguished scholarly contributions to the clinical practice of ophthalmology. This award was established as a tribute to... Read More